Near-infrared laser adjuvant for influenza vaccine.
Near-infrared laser adjuvant for influenza vaccine.
复制标题
DOI:
10.1371/journal.pone.0082899
复制
发表时间:
2013
期刊:
影响因子:
3.7
通讯作者:
Poznansky MC
中科院分区:
文献类型:
--
作者:
Kashiwagi S;Yuan J;Forbes B;Hibert ML;Lee EL;Whicher L;Goudie C;Yang Y;Chen T;Edelblute B;Collette B;Edington L;Trussler J;Nezivar J;Leblanc P;Bronson R;Tsukada K;Suematsu M;Dover J;Brauns T;Gelfand J;Poznansky MC
Safe and effective immunologic adjuvants are often essential for vaccines. However, the choice of adjuvant for licensed vaccines is limited, especially for those that are administered intradermally. We show that non-tissue damaging, near-infrared (NIR) laser light given in short exposures to small areas of skin, without the use of additional chemical or biological agents, significantly increases immune responses to intradermal influenza vaccination without augmenting IgE. The NIR laser-adjuvanted vaccine confers increased protection in a murine influenza lethal challenge model as compared to unadjuvanted vaccine. We show that NIR laser treatment induces the expression of specific chemokines in the skin resulting in recruitment and activation of dendritic cells and is safe to use in both mice and humans. The NIR laser adjuvant technology provides a novel, safe, low-cost, simple-to-use, potentially broadly applicable and clinically feasible approach to enhancing vaccine efficacy as an alternative to chemical and biological adjuvants.
登录
查看更多内容
DOI:
10.2471/blt.10.079426
发表时间:
2011-03-01
期刊:
Bulletin of the World Health Organization: International Journal of Public Health
影响因子:
--
作者:
Hickling, JK;Jones, KR;Kristensen, D
通讯作者:
Kristensen, D
影响因子:
2.1
作者:
BOULNOIS J-L
通讯作者:
BOULNOIS J-L
影响因子:
5.5
作者:
Kim YC;Quan FS;Yoo DG;Compans RW;Kang SM;Prausnitz MR
通讯作者:
Prausnitz MR
影响因子:
6.2
作者:
Ansaldi, Filippo;de Florentiis, Daniela;Icardi, Giancarlo
通讯作者:
Icardi, Giancarlo
影响因子:
3.7
作者:
Hovden, AO;Cox, RJ;Haaheim, LR
通讯作者:
Haaheim, LR